Vanguard Fiduciary Trust
CRL icon

Vanguard Fiduciary Trust’s Charles River Laboratories CRL Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.4M Sell
270,665
-6,330
-2% -$1.13M 0.01% 759
2026
Q1 		$47.8M Buy
+276,995
New +$51.4M 0.01% 810

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Fiduciary Trust's CRL Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Charles River Laboratories (CRL) stake by 2.3% in Q2 2026, selling an estimated $1.13M and leaving 270,665 shares worth $61.4M. The position accounts for 0.01% of the portfolio, ranked #759.

Vanguard Fiduciary Trust first reported a position in CRL in Q1 2026 and has held it in 2 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Vanguard Fiduciary Trust held 270,665 shares of Charles River Laboratories worth $61.4M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 6,330 Charles River Laboratories shares in Q2 2026, an estimated $1.13M.
  • Charles River Laboratories made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #759 holding.
  • Vanguard Fiduciary Trust first reported a position in Charles River Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.